Article ; Online: Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in ageing male: A retrospective study of 18 cases.
International journal of clinical practice
2020 Volume 74, Issue 8, Page(s) e13574
Abstract: ... patients who were admitted and treated to our hospital due to COVID-19.: Methods: Between March 18, 2020 ... and April 5, 2020, 18 patients admitted with COVID-19 who has BPH and are using medication ... for this were included in the study and analysed retrospectively. Diagnosis was confirmed by COVID-19 ...
| Abstract | Aim: A worldwide pandemic of coronavirus disease 2019 (COVID-19) which emerged in China in December 2019 affects the world very seriously. We aimed to evaluate the benign prostatic hyperplasia (BPH) patients who were admitted and treated to our hospital due to COVID-19. Methods: Between March 18, 2020 and April 5, 2020, 18 patients admitted with COVID-19 who has BPH and are using medication for this were included in the study and analysed retrospectively. Diagnosis was confirmed by COVID-19 nucleic acid test by sampling sputum or nasopharyngeal swab. Standard COVID-19 treatment protocol determined by our Ministry of Health was applied to all patients according to their risk groups. Epidemiological, clinical, radiological features, additional diseases, laboratory tests, complications and outcome data of all patients were recorded. Results: Mean age of patients was 59.6 (range: 56-73). As the mode of transmission, 10 (55.5%) of patients were infected in hospital, 5 (27.7%) patients had a relative with COVID-19 and three (16.6%) was unknown. During follow-up, 2 (11.1%) patients were transferred to intensive care unit (ICU). One of these patients dramatically progressed and died. Patients who survived and were not transferred to ICU had lesser comorbidities and were relatively young. Mean duration of hospitalisation was 14.2 days (range 12-19). Conclusion: We think that COVID-19 patients with BPH had a low mortality rate and did not have a poor prognosis in this patient group. It is crucial to take comprehensive preventive measures to control COVID-19 transmission via hospital route. |
|---|---|
| MeSH term(s) | Aged ; Betacoronavirus ; COVID-19 ; Comorbidity ; Coronavirus Infections/complications ; Coronavirus Infections/drug therapy ; Coronavirus Infections/therapy ; Hospitalization ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/therapy ; Prostatic Hyperplasia/complications ; Prostatic Hyperplasia/virology ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 |
| Keywords | covid19 |
| Language | English |
| Publishing date | 2020-06-23 |
| Publishing country | India |
| Document type | Journal Article |
| ZDB-ID | 1386246-7 |
| ISSN | 1742-1241 ; 1368-5031 |
| ISSN (online) | 1742-1241 |
| ISSN | 1368-5031 |
| DOI | 10.1111/ijcp.13574 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ua VI Zs.301: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.